What's breaking now, across thousands of outlets.
A confirmatory late-stage study is now also underway for what the startup is positioning as, potentially, the first oral alternative to approved injectables like Amgen's Tepezza and Viridian's Lumvoa.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Social media will be banned for children under 13 across the European Union according to the newly proposed “EU Kids Act”, announced by European Commission President Ursula von der Leyen today (16…
(MedPage Today) -- LONDON -- An appeals court judge issued a scathing report Tuesday that found dysfunctional management and a "complete failure" to protect babies at the British hospital where…
How a Reagan-era program to promote vaccine production could play a role in Kennedy’s crusade against the medications
Multiple cameras tracked a mouse as it wandered around a small arena. A computer charted its position and speed, leaving Pong-like traces on a monitor. The reason to watch this rodent so carefully?
King's College London spinout Algocyte has developed a small blood-testing device that connects via Bluetooth and uses AI to build a picture of an individual's health over time.
